Question

While the usual process followed by the U.S. Food and Drug Administration (FDA) requires that thorough...

While the usual process followed by the U.S. Food and Drug Administration (FDA) requires that thorough clinical trials have shown the benefits of a drug before approval is granted, an accelerated approval process is possible in some cases for drugs designed to treat some serious illnesses. Discuss a solution to the problem of addressing patients’ demands to accelerate clinical trials of new medicines while ensuring that the medicines are safe.

Homework Answers

Answer #1

Clinical trials are the research studies that are performed during the drug discovery process, they are intended to test the efficiency and side effects of drugs on humans. As the clinical trials of test drugs include humans as the testing subjects, appropriate drug designing is the only possible solution, because the safety measures cannot be compromised. Only the drugs that are completely non-toxic and effective in the pre-clinical trials must be allowed to clinical trials. Using in-silico techniques for drug designing will be more helpful to increase the chances of discovering a safe and effective drug.

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
Many consumer groups feel that the U.S. Food and Drug Administration (FDA) drug approval process is...
Many consumer groups feel that the U.S. Food and Drug Administration (FDA) drug approval process is too easy and, as a result, too many drugs are approved that are later found to be unsafe. On the other hand, a number of industry lobbyists have pushed for a more lenient approval process so that pharmaceutical companies can get new drugs approved more easily and quickly. The FDA wants to set up a hypothesis test to show that the new drug is...
The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response...
The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: In response to the demand for alcohol-based hand sanitizers and their active ingredient, alcohol, certain entities that are not currently regulated by the FDA as drug manufacturers have requested guidance on the preparation and distribution of alcohol for incorporation into hand sanitizer products for the public’s use. The FDA issued another guidance for industry about hand sanitizers, Temporary Policy...
You learn that the U.S. Food and Drug Administration (FDA) and the corresponding State of Georgia...
You learn that the U.S. Food and Drug Administration (FDA) and the corresponding State of Georgia agency, which are responsible for monitoring food safety, are understaffed and overworked. State and federal inspectors do not require the peanut industry to inform the public — or even the government — of salmonella contamination in its plants (i.e., disclosure is not mandated). You also learn that Georgia, like 42 other states, has arrangements with the FDA for Georgia health and safety personnel to...
TESTING DRUGS IN THE DEVELOPING WORLD The drug development process is long, risky, and expensive. It...
TESTING DRUGS IN THE DEVELOPING WORLD The drug development process is long, risky, and expensive. It can take ten years and cost in excess of $500 million to develop a new drug. Moreover, between 80 and 90 percent of drug candidates fail in clinical trials. Pharmaceutical companies rely upon a handful of successes to pay for their failures. Among the most successful of the world's pharmaceutical companies is New York–based Pfizer. Developing a new drug involves risks and costs, and...
Pfizer was established in 1849 in Brooklyn, New York by cousins Charles Pfizer and Charles Erhart...
Pfizer was established in 1849 in Brooklyn, New York by cousins Charles Pfizer and Charles Erhart with a loan of $2,500 from Pfizer’s father.2 Today, 167 years later, Pfizer Inc. has international revenues of $49 billion, which makes it the second-largest pharmaceutical manufacturer in the world.3 Despite Pfizer’s success, the company has faced many challenges over the last few decades. The pharmaceutical industry is heavily influenced by legal, political, and technological forces, and all indications are that the industry will...